PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting
Nov 1, 2012, 00:00
10.1016/j.jval.2012.08.1003
https://www.valueinhealthjournal.com/article/S1098-3015(12)02716-7/fulltext
Title :
PCV60 Cost Effectiveness of Dabigatran Etexilate for Prevention of Stroke and Systemic Embolism in Nonvalvular Atrial Fibrillation Patients in the Turkish Health Care Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(12)02716-7&doi=10.1016/j.jval.2012.08.1003
First page :
A373
Section Title :
Cardiovascular Disorders
Open access? :
No
Section Order :
512